Aster DM Healthcare Limited (ASTERDM) — Board Meeting(3 announcements)

Aster DM Healthcare announced board reshuffles effective 1 July 2026 following its merger with Quality Care India, appointing Varun Khanna as Managing Director & Group CEO and adding six new directors while four incumbents resigned. Senior management saw multiple designations and the resignation of Hitesh Dhaddha, with the ESOP scheme amended pending shareholder approval. The changes reflect post-merger integration and leadership continuity.

Aster DM Healthcare announced a board reshuffle effective 1 July 2026, appointing Varun Khanna as Managing Director & Group CEO and adding five new directors, while four independent directors resigned due to the Quality Care India merger. Senior management saw multiple designations and appointments, including Ramesh Kumar as CEO India I and Vishal Maheshwari as Group CFO. The filing also details amendments to the Employee Stock Option Scheme 2026, authorizing up to 1.53 crore shares with specific pricing and vesting terms.

The Board approved key appointments including Varun Khanna as Managing Director & Group CEO for 5 years and new independent directors, alongside resignations of four non-executive directors linked to the Quality Care India merger. Senior management changes include Dr. Somashekhar S P appointed Group Chief People Officer and Mr. Sunil Kumar as Group CFO, while Hitesh Dhaddha resigned as CIO & M&A Officer effective 18 July. The Board also amended the Employee Stock Option Scheme 2026, reserving 1.525 million shares with a pre-merger exercise price of ₹319.40 (30% discount) and post-merger discounts up to 20%, administered by the Nomination and Remuneration Committee with 1-5 year vesting.